Alentis Therapeutics appoints Dr Roberto Iacone as CEO
– SWITZERLAND, Basel – Alentis Therapeutics, the Swiss biotech developing breakthrough treatments for fibrotic diseases, today announced that Dr Roberto Iacone has been named CEO.…
Switzerland
Advertima closes €15m Series A funding led by Fortimo Group
– SWITZERLAND, St. Gallen – Advertima, an emerging computer vision platform provider, today announced the close of a €15 million Series A investment round led by existing shareholder Swiss real estate company, Fortimo Group.…
Quotient welcomes Dr Isabelle Buckle and Dr Catherine Larue to its Board of Directors
– SWITZERLAND, Eysins – Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, today announced the appointments of Dr.…
T3 Pharma raises CHF25m financing bringing total funding to date to CHF40m
– SWITZERLAND, Basel – T3 Pharmaceuticals AG, Swiss biotech advancing immuno-oncology with its bacteria-based protein delivery platform, today announced the closing of its third financing round, raising over 25M CHF in a round co-led by existing investors, including the Boehringer Ingelheim Venture Fund, Reference Capital, Wille Finance, as well as private investors also participating in the round.…
Virometix appoints Dr Axel Polack and CEO, Anna Sumeray to its Board and completes a CHF7.5m Series B funding
– SWITZERLAND, Schlieren – Virometix, a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and oncology diseases, today announced the successful completion of a CHF 7.5 million Series B equity financing round.…